# The interplay of APOE and APOA1 gene polymorphisms modulates the risk of type 2 diabetes mellitus in an obese population: a case–control study"

**Authors:** Nagla Usama, Amr E. Ahmed, Salma Mekheimer, Khaled Elhadidy, Mahmoud Farid

PMC · DOI: 10.1186/s40001-025-03829-0 · European Journal of Medical Research · 2026-01-27

## TL;DR

This study finds that specific genetic variations in APOE and APOA1 genes are linked to a higher risk of type 2 diabetes in obese individuals.

## Contribution

The study reveals independent associations of APOE ε4 and APOA1 rs5069 A alleles with obesity-related T2DM, despite no significant gene-gene interaction.

## Key findings

- APOE ε4 allele and ε4/ε4 genotype are significantly associated with obese T2DM compared to controls and euglycemic obese subjects.
- APOA1 rs5069 A allele and AA genotype are linked to both obesity and T2DM.
- APOE and APOA1 genotypes show positive co-occurrence in obese individuals but not in non-obese T2DM individuals.

## Abstract

Genetic factors play an important role in metabolic disease susceptibility. Apolipoproteins E (APOE) and A1 (APOA1) are key regulators of lipid metabolism and have been individually associated with dyslipidemia and type 2 diabetes mellitus (T2DM).

This study aimed to examine the individual and combined associations of APOE (rs429358, rs7412) and APOA1 (rs5069) gene polymorphisms with obesity and T2DM.

A case–control study was conducted including 350 participants categorized into four groups: controls (n = 100), euglycemic obese individuals (n = 100), obese individuals with T2DM (n = 100), and non-obese individuals with T2DM (n = 50). Biochemical parameters, including lipid profiles and glycemic indices, were assessed. Genotyping was performed using TaqMan® SNP genotyping assays.

Metabolic disturbances and dyslipidemia were observed across all patient groups, with the most pronounced abnormalities in obese individuals with T2DM. The APOE ε4 allele and ε4/ε4 genotype were significantly associated with obese T2DM compared with controls and euglycemic obese subjects. The APOA1 rs5069 A allele and AA genotype were associated with both obesity and T2DM. Spearman correlation analysis revealed a positive co-occurrence of APOE and APOA1 genotypes in euglycemic obese (ρ = 0.264, p = 0.008) and obese T2DM (ρ = 0.347, p < 0.001) groups, but not in non-obese T2DM individuals. However, in multivariate logistic regression models adjusted for age, sex, and BMI, the APOE × APOA1 interaction term did not reach statistical significance (p = 0.138).

APOE ε4 and APOA1 rs5069 A alleles were independently associated with obesity-related T2DM. Although these variants demonstrated correlated distribution patterns in obese individuals, the formal gene–gene interaction on T2DM risk was not statistically significant after multivariable adjustment. These findings suggest that obesity may represent a metabolic context in which combined genetic associations are more evident, warranting further investigation in larger and well-powered cohorts.

The online version contains supplementary material available at 10.1186/s40001-025-03829-0.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348], APOA1 (apolipoprotein A1) [NCBI Gene 335]
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), obesity (MONDO:0011122), dyslipidemia (MONDO:0002525)

## Full-text entities

- **Genes:** APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** Obese (MESH:D009765), T2DM (MESH:D003924), malignancy (MESH:D009369), Insulin resistance (MESH:D007333), Metabolic disturbances (MESH:D024821), type 1 diabetes mellitus (MESH:D003922), Diabetes (MESH:D003920), atherogenic (MESH:D050197), bone diseases (MESH:D001847), hepatic or renal impairment (MESH:D008107), cardiovascular disease (MESH:D002318), adiposity (MESH:D018205), Dyslipidemia (MESH:D050171), hypercholesterolemia (MESH:D006937), inflammation (MESH:D007249), smoking (MESH:D015208), metabolic disease (MESH:D008659)
- **Chemicals:** Lipid (MESH:D008055), glucose (MESH:D005947), E2 (MESH:D004958), 25(OH)D (-), free fatty acids (MESH:D005230), EDTA (MESH:D004492), cholesterol (MESH:D002784), E4 (MESH:D004953), triglyceride (MESH:D014280), 25-hydroxyvitamin D (MESH:C104450)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs2070665, 83 C> T, 2488 C> T, rs5069, rs429358, -75 G> A, C   T, rs670, A1C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849122/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849122/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849122/full.md

---
Source: https://tomesphere.com/paper/PMC12849122